{"nct_id":"NCT05546866","title":"Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRm","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2023-02-09","start_date_type":"ACTUAL","primary_completion_date":"2029-06-30","primary_completion_date_type":"ESTIMATED","completion_date":"2029-06-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}